Literature DB >> 22104306

Toll-like receptor--a potent driving force behind rheumatoid arthritis.

Michiaki Takagi1.   

Abstract

Toll like receptor (TLR), one of the key functions of innate immune system, can recognize not only exogenous pathogen-associated molecular patterns, namely PAMPs, but also endogenous molecules created upon tissue injury, sterile inflammation and degeneration. Endogenous TLR ligands are called as damage-associated molecular patters (DAMPs), including endogenous molecules released by activated and necrotic cells, and extracellular matrix molecules. DAMPs are also known as alarmins. TLR research has brought about new insights in the rheumatic diseases. Previous reports suggest that TLRs and the signal pathways intensively contribute to the pathogenesis of rheumatoid arthritis (RA) and other arthritic conditions with interaction of various TLR ligands. Accumulated knowledge of TLR system is summarized to overlook TLRs and the signaling pathway in arthritis conditions, with special reference to RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104306     DOI: 10.3960/jslrt.51.77

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  21 in total

1.  Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease.

Authors:  Teresa Requena; Irene Gazquez; Antonia Moreno; Angel Batuecas; Ismael Aran; Andres Soto-Varela; Sofia Santos-Perez; Nicolas Perez; Herminio Perez-Garrigues; Alicia Lopez-Nevot; Eduardo Martin; Ricardo Sanz; Paz Perez; Gabriel Trinidad; Marta E Alarcon-Riquelme; Roberto Teggi; Laura Zagato; Miguel A Lopez-Nevot; Jose A Lopez-Escamez
Journal:  Immunogenetics       Date:  2013-02-01       Impact factor: 2.846

Review 2.  Macrophages-Key cells in the response to wear debris from joint replacements.

Authors:  Christophe Nich; Yuya Takakubo; Jukka Pajarinen; Mari Ainola; Abdelhakim Salem; Tarvo Sillat; Allison J Rao; Milan Raska; Yasunobu Tamaki; Michiaki Takagi; Yrjö T Konttinen; Stuart B Goodman; Jiri Gallo
Journal:  J Biomed Mater Res A       Date:  2013-04-09       Impact factor: 4.396

Review 3.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  Joint replacement surgery and the innate immune system.

Authors:  Stuart B Goodman; Yrjo T Konttinen; Michiaki Takagi
Journal:  J Long Term Eff Med Implants       Date:  2014

5.  GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Authors:  Qin Chen; Peiliang Shi; Yufang Wang; Dayuan Zou; Xiuwen Wu; Dingyu Wang; Qiongyuan Hu; Yujie Zou; Zan Huang; Jianan Ren; Zhaoyu Lin; Xiang Gao
Journal:  J Mol Cell Biol       Date:  2019-06-01       Impact factor: 6.216

6.  The Biologic Response to Bearing Materials.

Authors:  Emmanuel Gibon; Stuart B Goodman
Journal:  Orthop Knowl Online       Date:  2016-06

7.  Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.

Authors:  Irina Fernandez; Lisa Harlow; Yunjuan Zang; Ru Liu-Bryan; William M Ridgway; Paula R Clemens; Dana P Ascherman
Journal:  J Immunol       Date:  2013-07-10       Impact factor: 5.422

Review 8.  The role of TLR and chemokine in wear particle-induced aseptic loosening.

Authors:  Qiaoli Gu; Qin Shi; Huilin Yang
Journal:  J Biomed Biotechnol       Date:  2012-10-21

9.  Isolated Toll-like receptor transmembrane domains are capable of oligomerization.

Authors:  James I Godfroy; Mohammad Roostan; Yurii S Moroz; Ivan V Korendovych; Hang Yin
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation.

Authors:  Endre Kiss-Toth; Edward Harlock; Darren Lath; Thomas Quertermous; J Mark Wilkinson
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.